Norleual
Based on 1 publication(s) in Google Scholar
Norleual, an angiotensin (Ang) IV analog, is a hepatocyte growth factor (HGF)/c-Met inhibitor with an IC50 of 3 pM. Norleual is an AT4 receptor antagonist and exhibits potent antiangiogenic activities.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 334994-34-2
- Fòrmula: C41H58N8O7
- Peso molecular:774.95
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Norleual
MoreVer todos los productos específicos de isoformas Angiotensin Receptor
More
Actividad biológica
Descripciòn
In Vitro
Norleual at 20 and 50 pM significantly reduces HGF-dependent c-Met and Gab1 phosphorylation. 20 pM Norleual dramatically reduces HGF-initiated association between Gab1 and c-Met in HEK293 cells. Norleual markedly attenuates HGF-dependent c-Met activation and downstream signaling[1]. Norleual (1 pM-1 μM; 4 days) is able to inhibit HGF-dependent signaling, proliferation, migration, and invasion in multiple cell types at concentrations in the picomolar range in MDCK cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Chemical Information
-
No. CAS 334994-34-2
-
Peso molecular 774.95
-
Fòrmula C41H58N8O7
-
Sequence
{Nle}-Tyr-{Leu-Ψ-(CH2-NH2)}-His-Pro-Phe
-
Sequence Shortening
{Nle}-Y-{Leu-Ψ-(CH2-NH2)}-HPF
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)